Titan Pharmaceuticals — Fact Sheet (March 2015)
5 slides from Titan Pharmaceuticals's fact sheet, Mar 9, 2015
Slide 1: Company Fact Sheet: Titan Pharmaceuticals Overview
Exhibit 99.1 COMPANY FACT SHEET Titan Pharmaceuticals Overview Titan Pharmaceuticals Inc. (TTNP.OB), based in South San Francisco, CA, is a specialty phar-maceutical company developing proprietary therapeutics utilizing its ProNeura™ implant drug delivery technology. ProNeura provides non-fluc-tuati
Slide 2: Slide 2
Slide 3: Slide 3
Slide 4: Probuphine Clinical Development & Commercialization Program
Probuphine Clinical Development & Commercialization Program A final Phase 3 trial of Probuphine is in progress, with results expected by mid-2015. Pa-tient enrollment is complete in this two-arm double blind, double dummy, non-inferiority study in stable patients receiving maintenance treatment with
Slide 5: Slide 5